Zhining Xia

Zhining Xia


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2019 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
MWMin Wang
Min Wang
YWYuyan Wan
Yuyan Wan
KZKailian Zhang
Kailian Zhang
QFQifeng Fu
Qifeng Fu
LWLujun Wang
Lujun Wang
DGDie Gao
Die Gao

1 June 2016 in TrAC Trends in Analytical Chemistry
Verified
Journal Article
Closed access
QZQihui Zhang
Qihui Zhang
LZLian-Di Zhou
Lian-Di Zhou
HCHua Chen
Hua Chen
CWChong-Zhi Wang
Chong-Zhi Wang
ZXZhining Xia
Zhining Xia
CYChun-Su Yuan
Chun-Su Yuan

1 November 2019 in Environmental Pollution
Verified
Journal Article
Closed access
RSRong Shen
Rong Shen
YYYichang Yu
Yichang Yu
RLRong Lan
Rong Lan
RYRan Yu
Ran Yu
ZYZe Yuan
Ze Yuan
ZXZhining Xia
Zhining Xia

1 December 2018 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
YHYike Huang
Yike Huang
LHLu Hu
Lu Hu
SHShan Huang
Shan Huang
WXWanjun Xu
Wanjun Xu
JWJingyuan Wan
Jingyuan Wan
ZXZhining Xia
Zhining Xia
Background: The main objective of this study was to develop novel BSA nanoparticles (BSA NPs) for improving the bioavailability of curcumin as an anticancer drug, and those BSA NPs were galactosylated for forming the curcumin-loaded galactosylated BSA nanoparticles (Gal-BSA-Cur NPs), thus enhancing their ability to target asialoglycoprotein receptor (ASGPR) overexpressed on hepatocellular carcinoma (HCC) cells. Materials and methods: Gal-BSA-Cur NPs were prepared by the desolvation method and showed a spherical shape and well distribution with the average particle size of 116.24 nm. Results: In vitro drug release assay exhibited that Gal-BSA-Cur NPs had higher release rates and improved the curcumin solubility. Cell uptake studies confirmed that Gal-BSA-Cur NPs could selectively recognize receptors on the surface of HCC (HepG2) cells and improve internalization ability of drug compared with BSA NPs-loaded curcumin (BSA-Cur NPs), which might be due to high affinity to galactose. Further, the effects of Gal-BSA-Cur NPs were evaluated by cytotoxicity assay, crystal violet assay, cell apoptosis assay, and wound healing assay, respectively, which revealed that Gal-BSA-Cur NPs could inhibit HepG2 cells proliferation, induce cell apoptosis, and inhibit cell migration. Conclusion: Immunofluorescence staining has proved that the effects of Gal-BSA-Cur NPs related to the suppression of the nuclear factor κB-p65 (NF-κB-p65) expression in HepG2 cell nucleus. Therefore, these results indicate that novel Gal-BSA-Cur NPs are potential candidates for targeted curcumin delivery to HCC cells.

1 July 2019 in Microchemical Journal
Verified
Journal Article
Closed access
YWYuyan Wan
Yuyan Wan
MWMin Wang
Min Wang
KZKailian Zhang
Kailian Zhang
QFQifeng Fu
Qifeng Fu
MGManjie Gao
Manjie Gao
DGDie Gao
Die Gao

1 October 2018 in Biochemical Engineering Journal
Verified
Journal Article
Closed access
WXWan-Jun Xu
Wan-Jun Xu
YHYi-Kei Huang
Yi-Kei Huang
FLFeng Li
Feng Li
DWDan-Dan Wang
Dan-Dan Wang
MYMan-Ni Yin
Man-Ni Yin
ZXZhining Xia
Zhining Xia